Publication AWA

At the Public Information Bulletin of the Agency for Health Technology Assessment and Tarification (AWA) has published reviews analyses for the evaluation of reimbursement application:

• Tagrisso (osimertinib) in the treatment of patients with lung cancer and pleural mesothelioma

We encourage you to read the full documents and submit comments within the prescribed period of 7 days from the date of publication.